American Portfolios Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$593 Sell
127
-1,250
-91% -$7.88K ﹤0.01% 3359
2022
Q2
$8.15K Sell
1,377
-7,000
-84% -$77.9K ﹤0.01% 2651
2022
Q1
$162K Sell
8,377
-400
-5% -$9.17K 0.01% 1272
2021
Q4
$287K Sell
8,777
-75
-0.8% -$3.02K 0.01% 982
2021
Q3
$363K Sell
8,852
-1,413
-14% -$51.3K 0.01% 854
2021
Q2
$370K Sell
10,265
-11,365
-53% -$419K 0.01% 854
2021
Q1
$844K Buy
21,630
+9,850
+84% +$443K 0.04% 465
2020
Q4
$475K Buy
11,780
+10,725
+1,017% +$493K 0.02% 569
2020
Q3
$58.7K Buy
+1,055
New +$55.9K ﹤0.01% 1265

Other funds holding GDRX

American Portfolios Advisors's GDRX Position: Q3 2022 in Review

American Portfolios Advisors reduced its GoodRx Holdings (GDRX) stake by 91% in Q3 2022, selling an estimated $7.88K and leaving 127 shares worth $593. The position accounts for ﹤0.01% of the portfolio, ranked #3359.

American Portfolios Advisors first reported a position in GDRX in Q3 2020 and has held it in 9 quarters since. The position peaked at $844K in Q1 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

  • American Portfolios Advisors held 127 shares of GoodRx Holdings worth $593 as of Q3 2022.
  • American Portfolios Advisors sold 1,250 GoodRx Holdings shares in Q3 2022, an estimated $7.88K.
  • GoodRx Holdings made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3359 holding.
  • American Portfolios Advisors first reported a position in GoodRx Holdings in Q3 2020 and has held it in 9 quarters since.
  • American Portfolios Advisors's GoodRx Holdings position peaked at $844K in Q1 2021.
  • 180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.